in the footnote of each figure and table. 3 . Collection of urine, feces, expired air, gastric juice and bile
For the separate collection of urine, feces and expired air, rats were individually placed in all-glass cages. Air was introduced into the cage at a rate of 500 ml/min and the issuing air was passed through traps containing 5 N potassium hydroxide solution. Blood was sampled from the tail vein. The volume of the circulating blood was assumed to be 6% of the body weight. After opening the peritoneal cavity a polyethylene cannula was inserted into the pyloric end via pyloric ring and was ligated for the collection of the gastric juice in vivo.
The operated animals were then placed in restraining cages. During experimental period, they were allowed free access to water, so that gastric juice was washed out into test tube placed beneath the cages. The animals were received subcutaneously with 10 ml of the nutrient mixture containing 2.5% amino acids mixture (Polytamin, Takeda Chem. Ind. Ltd.), 10% glucose and 0.9% sodium chloride, twice daily. Bile was collected from the cannula inserted into the common bile duct. The bile duct-cannulated rats were immobilized in restraining cages with free access of food and water.
Whole-body autoradiography in mice
At appropriate time intervals after the oral administration of SIN-10-14C, the animals were anesthetized with ether and rapidly frozen by immersion in a mixture of acetone and solid carbon dioxide. After removal of the limbs and tails, the frozen bodies were em bedded in an aqueous solution of 10 %carboxymethyl cellulose gel, and the whole-body sections with the thickness of 40 to 60 p were prepared according to the method of Ullberg (5) . The air-dried sections were kept in close contact with Fuji No-Screen X-ray film and exposed for 2 weeks.
5. Gastrointestinal absorption a) Gastric absorption in the pylorus-ligated rats : The surgical exposure of the stomach in the anesthetized rats was followed by the ligation of the cardia and the cannulation into the pylorus. The method of Schanker et al. (6) was used for the gastric absorption studies. After repeated washing of the gastric lumen with saline, 4 ml of either 0.15 M sodium chloride or 0.15 M sodium bicarbonate solution containing 300 pg/ml of SIN-10 warmed at body temperature were infused intragastrically via the pyloric cannula. Phe nol red was added to the drug solution at the concentration of 40 ag/ml so as to correct any volume change, because the indicator is known to be unabsorbed. The concent rations of the drug and indicator were determined at the initial and varying time intervals. The percent absorption of the drug was calculated from the following equation, in which C represents concentration.
Per cent absorbed= 100 100 Cdrug t-time x Cindicator o-time -Cdrug o-time Cindicator t-time b) Intestinal absorption in vivo : The technique used was based on the method of Schanker et al. (7) . The proximal end of the duodenum and the distal end of the ileum were cannulated in the anesthetized rats for the intraluminal perfusion. The perfusion solution, maintained at 37'C, was perfused at a rate of 1.5 ml/min. The relative rate of absorption was calculated, as descrived above. c) Intestinal absorption in vitro : The transference of SIN-10 from the mucosal side to the serosal one was studied with everted sacs of small intestine, prepared by the method of Wilson and Wiseman (8) . The small intestine was excised from a rat weighing 214 g. The entire gut was everted by using a glass rod and was divided into 8 parts almost equal in length. These sections were filled with 2.5 ml of the medium and incubated with 20 ml of the medium containing SIN-10 at 37°C in an atmosphere of 5% carbon dioxide in 95% oxygen. The transfer of the radioactivity into the serosal fluids after 60 minutes of the incubation was measured for the calculation of the absorptive transference. Volume change of the inside solution during incubation was corrected by phenol red, as described above. 6. Measurement of the radioactivity The radioactivity was measured by liquid scintillation counter (Nihon Musen Co., ALOKA (model LSC-502). Corrections were made for quenching or counting efficiency. Usually 0.1 ml of aliquots of the urine and bile were placed in vials containing 10 ml of scintillation phosphor solution, having the following formulation : 2, 5-diphenyloxazole (PPO), 3 g; 1, 4-bis (2-(5-phenyl-oxazolyl)) benzene (POPOP), 150 mg; naphthalene, 60 g; dioxane, 1000 ml and ethylcellusolve, 200 ml. The radioactive carbon in blood, tissues, feces and contents of the stomach and intestine were determined by the combustion method of Davidson and Oliverio (9) . Usually 100 mg of freez-dried samples were subject to combustion and the formed carbon dioxide was absorbed in 10 ml of 1 M Hyamine hydro xide in methanol, of which 3 ml aliquots were added with 10 ml of a toluol-phosphor solution (PPO, 3 g; POPOP, 100 mg per liter of toluol). The radioactive carbon dioxide in the expired gas was first trapped in 5 N potassium hydroxide solution placed in a metabolic cage. An aliquot of the alkaline solution was then transferred into a flask which had a central well containing the Hyamine solution. The carbon dioxide, after evaporated by adding an excess of sulfuric acid to the alkaline solution, was resorbed in the Hyamine solution for the counting of the radioactivity, as described above.
RESULTS

Autoradiographic findings
The autoradiographic picture of the mice received the single oral dose of SIN-10 is shown in Fig. 1 . Considerable radioactivity was already detected in almost all tissues 10 minutes after the administration, though its appearance in the brain was somewhat delayed. A large amount of the unabsorbed radioactivity was found in the stomach. The peak level in the radioactivity in most tissues was observed about 30 minutes after the administration. Thereafter, the tissue levels declined rapidly. No noticeable ac cumulation of radioactivity have been observed, except the stomach and its contents, in which considerable amounts of radioactivity still remained even after 48 hours. This finding suggested a gastric secretion of radioactivity. FiG.2. Blood radioactivity after oral administration of SIN-10-14C in rats. Dose, 6 mg (7.2 pc)/kg of body weight. The data were obtained from three rats, weighing 171 g in average and were expressed as SIN-10 in mean--S.D. Fig. 2 shows the time-course of the levels of radioactivity in the blood of the rats re ceived orally SIN-10. An appreciable radioactivity was already observed in the circu lating blood 1 minute after the administration. The level attained a maximum of 4.4
Blood level
,ug/ml, expressed as SIN-10, at 1 hour after the administration and thereafter declined rather slowly with the half-life time of 3.5 hours. The level at 24 hours was about one fifth of the peak level.
Immediately after the intravenous injection, the radioactivity in the blood declined rapidly (Fig. 3) . During the first 10 minutes 82.4% of the administered radioactivity, calculated by subtracting the amount in blood from the injected amount, was lost from the blood. The radioactivity in the blood declined in two phases with the half-life times of about 3 and 67 minutes, respectively.
Excretion and tissue distribution
The excretion and tissue distribution of the radioactivity in the rats recieved SIN-l0 orally are shown in Fig. 4 and Table 1 . Approximately 85% of the administered dose was found in the first 24 hour urine, whicle about 4% was excreted into the stool and less than 1 % in the expired air. Total recovery of the radioactivity from the urine, feces, expired air and gastrointestinal contents comprised 95.8% of the dose. within 48 hours, only 3 % remaining in the body (Table 1) .
Tissue distributions of the radioactivity at 0.5 and 48 hours are compiled in Table 1 . At 0.5 hour postadministration, the radioactivity was distributed in all tissues examined, in accordance with the results of whole-body autoradiograms of mice (Fig. 1) . Relatively higher levels were noted in the stomach, kidney, intestine and liver. Thus, 37.1% of the ingested dose was retained in the body, whereas 6.6% appeared in the urine. At 48 hours after administration, the radioactivity in the tested tissues was almost negligibly low, except the stomach, blood and liver which had significant amounts of radioactivity. Thus, 86.2 and 4.5% of the administered radioactivity were excreted into the urine and feces, respectively, whereas only 3% was retained in the body. Of the tested tissues, the stomach showed the highest specific radioactivity and gastric contents still contained about 1 % of the dosed radioactivity. These facts suggested an occurrence of gastric secretion of the drug or its metabolites.
Site of absorption a) Gastric absorption
Gastric absorption was then checked on, the pylorus-ligated rats (Fig. 5) . No appre ciable absorption was noted when the drug was introduced into the stomach in the sodium chloride solution, whose pH fell down to 2 within 30 minutes. On the other hand, con siderable amounts of the drug was absorbed when the drug was dissolved in the sodium bicarbonate solution. In this case, the pH value of the solution remained unchanged between 8.0 to 8.3 during the 2 hour's ex perimental period. These results led us to conclude that no gastric absorption could occur in intact rats under physiological conditions. b) Intestinal absorption As shown by the in situ perfusion ex periments (Fig. 6) , the drug was rapidly absorbed from the small intestine. Con sistent results were also obtained in the ex periments using everted sacs ' of the small intestine (Fig. 7) . The results also showed that .SIN-10 was absorbed more readily in the upper portion of the intestine than in the lower one. Radioactive carbon trans ported to the serosal sides was identified as unchanged SIN-10 by thin-layer chromato graphic examinations (Fig. 8 ).
Gastrointestinal excretion of radioactivity
The `above mentioned results on tissue distribution and balance studies ( Fig. 1 and Table 1 ) suggested the occurrence of gastric and biliary excretions of radioactivity. To ascertain the possibility, the following experiments using pylorus-ligated or bile duct cannulated rats were performed. a) Gastric secretion Cumulative gastric secretion of radioactivity after the intravenous injection of SIN 10 is presented in Fig. 9 . The recoveries of radioactivity in the gastric juice and urine after the administration of different dosing sizes and routes were summarized in Table 2 . Following an intravenous injection of 6 mg/kg of SIN-10, about 13% of the dose was ex creted into the stomach during the first 24 hours, whereas 65% was eliminated into the urine. Intraduodenal administration of the same dose or much larger dose of 340 mg/kg did not significantly change this excretion pattern. This fact also supports the rapid and well absorption.of the orally administered drug, as mentioned above. b) Biliary excretion Following the oral administration of SIN-10 to bile duct-cannulated rats, 4.6% of the dosed radioactivity was excreted into the bile for the first 24 hours. As shown in Fig. 10 , the excretion preceded almost linearly with time.
DISCUSSION
The metabolic fate of SIN-10, con cerning its absorption, tissue distribution and excretion, is schematically summarized in Fig. 11 , of which some points will be discussed.
An efficient gastrointestinal absorption of SIN-10 was evidenced by the following findings, 1) autoradiographic findings showing rapid and even distribution of the radioactivity in many of tissues after oral administra tion ( Fig. 1) , 2) immediate appearance of the radioactivity into the circulating blood after oral administration (Fig. 2), 3 ) results of balance studies (Table 1) showing that about half of the oral dose was absorbed during the first 30 minutes, 4) urinary excretion exceeding 40% of the orally administered radioactivity during the first 4 hours (Fig. 4) , 5) results obtained on pylorus-ligated rats ( excreted in the gastric juice and urine after oral administration of a massive dose of 340 mg/kg were almost the same as those observed after intravenous injection of 6 mg/kg. All these results supported the rapid and well absorption of SIN-10.
It was concluded by the data in Figs. 5, 6, 7 and 8 that SIN-l0 was absorbed un changed, mainly from upper portion of the small intestine and no gastric absorption occurred under physiological conditions. The finding that SIN-10 could be absorbed from the stomach in alkaline pH (Fig. 5 ) might be explained by passive transport due to simple diffusion, because the drug exists in undissociated form under alkaline condition, which is more lipophilic and thus expected to be more permeable to lipid membrane than its dissociated form (10) .
The rapid diffusion of SIN-10 to various tissues from the circulating blood was clearly shown by the data presented in Fig. 3 , in which blood radioactivity rapidly declined after intravenous injection of SIN-10. The largest part of radioactivity disappeared from the blood, might diffuse to the entire body, as juged from the results of tissue distribution studies in rats (Table 1 ) and autoradiograms of mice (Fig. 1) .
As can be seen from the autoradiographic data, the distributed radioactivity disap peared very rapidly in the tissues and no specific long-lasting accumulation have been observed, except the stomach which was one of the sites of the excretion of SIN-10 or its metabolites. No accumulation of the radioactivity was further comfirmed by the results of balance studies (Fig. 4 and Table 1 ), which showed that most of the radioactivity ad ministered was largely eliminated via kidneys and only 3% remained in the body at 48 hours ( Table 1) . The present studies also demonstrated that considerable amount of the ingested radio activity were excreted into the gastrointestinal tract with gastric juice (13.4%, Table 3 ), as well as bile (4.6%, Fig. 10 ). Nevertheless, only less than 5 % of the dose was recovered in the 48 hours feces (Table 1) . These results clearly indicate the resorption of the radio activity excreted into the gastrointestinal tract via two routes mentioned above.
SUMMARY
Absorption, blood level, tissue distribution and elimination were studied mainly on rats following administration of 14C-labeled 5-ethoxycarbonyl-3-mo.rpholinosydnonimine. Blood radioactivity attained its maximum 1 hour after oral administration and gradually decreased with half-life time of 3.5 hours, whereas it declined rapidly in two phases with respective half-life times of 3 and 67 minutes following intravenous injection. Of the orally administered radioactivity, 85, 4.5 and 0.5% were excreted in the urine, feces and expired air during the first 24 hours. Thus, 93% was eliminated from the body within 48 hours. The drugs was absorbed unchanged from upper portion of the small intestine, but not from the stomach. Distribution studies, including whole-body autoradiograms of mice, indicated that the drug was rapidly absorbed, distributed evenly in the entire body with higher radioactivity in the stomach, kidney, intestine and liver. After 24 hours, the radioactivity was fairly eliminated from the body except the stomach. Some portion of the absorbed radioactivity was excreted into the gastrointestinal tract with the gastric juice and bile, most of which was largely resorbed, only small amounts being lost in the feces.
